CMS
60
2
SLG
57
-3
GME
66
-5
AXP
67
-2
AON
54
2
ED
45
3
DHI
44
-3
SCHW
62
-2
KMX
61
-3
CI
45
-3
BBY
52
6
BMY
55
-8
MS
77
-2
ICE
59
-3
SWKS
38
-2
FTI
71
-7
TEL
60
-8
NWS
75
-4
IFF
47
-4
K
51
-3
CMS
60
2
SLG
57
-3
GME
66
-5
AXP
67
-2
AON
54
2
ED
45
3
DHI
44
-3
SCHW
62
-2
KMX
61
-3
CI
45
-3
BBY
52
6
BMY
55
-8
MS
77
-2
ICE
59
-3
SWKS
38
-2
FTI
71
-7
TEL
60
-8
NWS
75
-4
IFF
47
-4
K
51
-3
Financhill
Back

Blackrock Debt Strategies Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
60

DSU
Blackrock Debt Strategies Fund

Last Price:
10.86
Seasonality Move:
2.01%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
60
Blackrock Debt Strategies Fund (DSU) is a Buy

Is Blackrock Debt Strategies Fund a Buy, Sell or Hold?

  • The current Blackrock Debt Strategies Fund [DSU] share price is $10.86. The Score for DSU is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • DSU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DSU Stock Price Chart

What is Blackrock Debt Strategies Fund's stock price today?

  • The Blackrock Debt Strategies Fund share price today is $10.86
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DSU is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DSU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 47.29 Sell
Chaikin Money Flow: 306791 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.8 - 10.94) Sell
Bollinger Bands (100): (10.81 - 11.01) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DSU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.89 Sell
20-day SMA: 10.86 Buy
50-day SMA: 10.95 Sell
200-day SMA: 10.93 Sell
8-day EMA: 10.88 Sell
20-day EMA: 10.89 Sell
50-day EMA: 10.91 Sell
200-day EMA: 10.82 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Blackrock Debt Strategies Fund Earnings Growth & DSU Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Blackrock Debt Strategies Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):